Paper Details

  1. Home
  2. Paper Details

Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.

Author: BorchmannPeter, BöllBoris, DiehlVolker, EichenauerDennis A, ElgerLeonard, EngertAndreas, FuchsMichael, GoergenHelen, KreisslStefanie, MüllerHorst, von TresckowBastian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Non-Hodgkin lymphoma (NHL) after Hodgkin lymphoma (cHL) is rare, happening in about 1.5% of patients. It usually occurs in older people, with the median age at diagnosis being 54 years old. The average time until developing NHL after cHL is 44 months, and the five-year survival rate is only about 44%. This suggests that NHL after cHL is often fatal.
Paper Details　
Original Abstract of the Article :
Data on non-Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first-line treatment within the randomized German Hodgkin Study Group (GHSG) HD7-HD15 studies. After a median follow-up of 106 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/bjh.17327

データ提供：米国国立医学図書館（NLM）

Non-Hodgkin Lymphoma After Hodgkin Lymphoma Treatment: A Rare but Significant Event

Hodgkin lymphoma, a type of cancer that affects the lymphatic system, is like a desert oasis that can be overcome with proper treatment. However, some individuals who have been successfully treated for Hodgkin lymphoma may face the risk of developing a second type of lymphoma, Non-Hodgkin lymphoma (NHL). This study, like a group of researchers carefully mapping the long-term health outcomes of Hodgkin lymphoma survivors, explores the occurrence of NHL in individuals previously treated for Hodgkin lymphoma. Researchers meticulously analyzed data from a large cohort of Hodgkin lymphoma patients treated within the German Hodgkin Study Group, tracking their health status over time.

Non-Hodgkin Lymphoma After Hodgkin Lymphoma Treatment: A Rare but Significant Event

The study revealed that NHL development after Hodgkin lymphoma treatment is a rare but significant event, affecting approximately 1.5% of patients.

Non-Hodgkin Lymphoma After Hodgkin Lymphoma Treatment: A Rare but Significant Event

This study underscores the importance of long-term monitoring for NHL in individuals who have been treated for Hodgkin lymphoma.

Dr.Camel's Conclusion

This study highlights the potential risk of developing Non-Hodgkin lymphoma after Hodgkin lymphoma treatment, emphasizing the need for vigilant monitoring and early detection of this secondary malignancy.
Date :
  1. Date Completed 2021-09-27
  2. Date Revised 2021-09-27
Further Info :

Pubmed ID

33486762

DOI: Digital Object Identifier

10.1111/bjh.17327

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.